Brokerages Set Tourmaline Bio, Inc. (NASDAQ:TRML) Target Price at $54.00
Shares of Tourmaline Bio, Inc. (NASDAQ:TRML – Get Free Report) have received an average rating of “Buy” from the six brokerages that are currently covering the firm, Marketbeat.com reports. Six analysts have rated the stock with a buy recommendation. The average 12-month price target among brokerages that have updated their coverage on the stock in […]
Shares of Tourmaline Bio, Inc. (NASDAQ:TRML – Get Free Report) have received an average rating of “Buy” from the six brokerages that are currently covering the firm, Marketbeat.com reports. Six analysts have rated the stock with a buy recommendation. The average 12-month price target among brokerages that have updated their coverage on the stock in […]
